NCT04707105 Prospective Cohort Study of Intracerebral Hemorrhage
| NCT ID | NCT04707105 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, Zhejiang University, School of Medicine |
| Condition | Intracerebral Hemorrhage |
| Study Type | OBSERVATIONAL |
| Enrollment | 856 participants |
| Start Date | 2020-12-29 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 856 participants in total. It began in 2020-12-29 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators design a prospective, observational cohort study to provide contemporary information on the prevalence, characteristics, risk stratification，cost-effective ,treatments and prognosis of Chinese hospitalised adult patients with intracerebral hemorrhage.
Eligibility Criteria
Inclusion Criteria: * Hospitalized patients over 18 years old of primary intracerebral hemorrhage. Exclusion Criteria: 1. patients of secondary intracerebral hemorrhage，such as hemorrhagic transformation of ischemic stroke, aneurysmal, cavernomas, arterio- venous malformations, central venous thrombosis, trauma-related, or tumor. 2. isolated intraventricular hemorrhage or subarachnoid hemorrhage pregnant patients； 3. surgical evacuation of hematoma； 4. unavailability to get complete blood cell samples and presenting contraindications or refusal to MRI 5. patients cannot be followed up for any reasons. 6. patients death in 24 hours 7. pregnant patients
Contact & Investigator
Feng Gao, MD,PhD
PRINCIPAL INVESTIGATOR
Second Affiliated Hospital, Zhejiang University, School of Medicine
Frequently Asked Questions
Who can join the NCT04707105 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intracerebral Hemorrhage. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04707105 currently recruiting?
Yes, NCT04707105 is actively recruiting participants. Contact the research team at 2202012@zju.edu.cn for enrollment information.
Where is the NCT04707105 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT04707105 clinical trial?
NCT04707105 is sponsored by Second Affiliated Hospital, Zhejiang University, School of Medicine. The principal investigator is Feng Gao, MD,PhD at Second Affiliated Hospital, Zhejiang University, School of Medicine. The trial plans to enroll 856 participants.